Singapore markets close in 3 hours 11 minutes

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.49+0.24 (+3.31%)
At close: 04:00PM EDT
7.36 -0.13 (-1.74%)
After hours: 07:37PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
285,382
351,367
48,633
0
0
Operating expenses
Research development
170,267
167,205
38,023
10,170
6,675
Selling general and administrative
49,568
45,785
21,640
4,438
2,802
Total operating expenses
219,835
212,990
59,663
14,608
9,477
Operating income or loss
65,547
138,377
-11,030
-14,608
-9,477
Income before tax
65,800
138,590
-10,947
-14,034
-9,064
Income tax expense
17,400
17,400
-
-
-
Income from continuing operations
48,400
121,190
-10,947
-14,034
-9,064
Net income
48,400
121,190
-10,947
-14,034
-9,064
Net income available to common shareholders
48,400
121,190
-10,947
-14,034
-9,064
Basic EPS
-
-
-0.51
-0.32
-0.19
Diluted EPS
-
-
-0.51
-0.32
-0.19
Basic average shares
-
-
21,592
43,737
47,293
Diluted average shares
-
-
21,592
43,737
47,293
EBITDA
-
138,406
-11,011
-14,591
-9,460